LEP and osteoarthritis: Patients with degenerative joint disease, when exposed to leptin, respond by producing proinflammatory cytokines such as IL-8, IL-6, and TNF-alpha, which may intensify the catabolism of proteoglycans, increase the expression of metalloproteinases (MMP), and thereby stimulate cartilage degradation.